May 2020

News

May 4, 2020

Noble Life Sciences is Granted Renewal of Full Accreditation from AAALAC – Noble Life Sciences

Sykesville, MD; March 13, 2020- Noble Life Sciences is excited to announce renewal of full…

Super User 0

Love0

News

May 4, 2020

AstraZeneca Joins U. of Oxford and Spinout to Develop COVID-19 Vaccine

AstraZeneca will oversee global development, manufacturing, and distribution of the COVID-19 vaccine candidate that was…

Super User 0

Love0

Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large scale distribution of the COVID 19 vaccine candidate Vaccitech

News

May 4, 2020

Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large-scale distribution of the COVID-19 vaccine candidate – Vaccitech

Vaccitech Ltd and the University of Oxford today announce an agreement with the UK-based global…

Super User 0

Love0

News

May 4, 2020

FIRST PATIENT DOSED IN AVDORALIMAB PHASE II CLINICAL TRIAL IN COVID-19 PATIENTS WITH SEVERE PNEUMONIA

Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”)…

Super User 0

Love0

Risks and Implications of Post Hoc Changes to the Borrower Certification Requirements What PPP Borrowers Need to Know Insights Venable LLP

News

May 4, 2020

Risks and Implications of Post Hoc Changes to the Borrower Certification Requirements: What PPP Borrowers Need to Know | Insights | Venable LLP

Since the enactment of the CARES Act, the Small Business Administration and U.S. Department of…

Super User 0

Love0

News

May 4, 2020

NIH mobilizes national innovation initiative for COVID-19 diagnostics

The National Institutes of Health today announced a new initiative aimed at speeding innovation, development…

Super User 0

Love0

This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19). (CDC/Alissa Eckert, MS)

News

May 4, 2020

NIAID: Gilead’s Remdesivir Shows Positive Proof of Concept in Hospitalized COVID-19 Patients

Gilead Sciences’ closely-watched COVID-19 drug candidate remdesivir outperformed placebo in a clinical trial sponsored by…

Super User 0

Love0

News

May 4, 2020

Gilson and QIAGEN Announce Collaboration Aiming to Make Manual Nucleic Acid Extraction More Efficient and Reproducible

Gilson and QIAGEN have entered into a strategic partnership that will provide researchers the ability…

Super User 0

Love0

News

May 4, 2020

NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic | TechCrunch

Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of…

Super User 0

Love0

Noble Life Sciences is Granted Renewal of Full Accreditation from AAALAC – Noble Life Sciences

AstraZeneca Joins U. of Oxford and Spinout to Develop COVID-19 Vaccine

Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large-scale distribution of the COVID-19 vaccine candidate – Vaccitech

FIRST PATIENT DOSED IN AVDORALIMAB PHASE II CLINICAL TRIAL IN COVID-19 PATIENTS WITH SEVERE PNEUMONIA

Risks and Implications of Post Hoc Changes to the Borrower Certification Requirements: What PPP Borrowers Need to Know | Insights | Venable LLP

NIH mobilizes national innovation initiative for COVID-19 diagnostics

NIAID: Gilead’s Remdesivir Shows Positive Proof of Concept in Hospitalized COVID-19 Patients

Gilson and QIAGEN Announce Collaboration Aiming to Make Manual Nucleic Acid Extraction More Efficient and Reproducible

NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic | TechCrunch

About BioHealth Innovation

Contact

Connect